Skip to content

Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial

Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04801069
Acronym
PISTACIO
Enrollment
60
Registered
2021-03-16
Start date
2021-03-15
Completion date
2023-09-15
Last updated
2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke, Sleep Apnea Syndromes

Brief summary

Sleep Apnea Syndrome (SAS) is highly prevalent in acute stroke and it is related to worst outcome. We aim to assess if SAS treatment, started immediately after acute ischemic stroke, impacts infarct growing and clinical prognosis.

Interventions

AirCurve 10CS PaceWave (Resmed)

Sponsors

SOS Attaque Cérébrale
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute ischemic stroke on brain MRI * NIHSS 6-22 * thrombolysis

Exclusion criteria

* Previous SAS * Previous stroke * Auto-adaptative Servo-Ventilation Contraindication

Design outcomes

Primary

MeasureTime frameDescription
Infarct progression7 daysIschemic size at 7 days compared to ischemic size at admission on brain MRI

Secondary

MeasureTime frameDescription
Neurological outcome on NIHSS3 monthsNational Institute of Health Stroke Scale (NIHSS), from 0 (normal neurological examination) to 42
Duration of Auto-adaptative Servo-Ventilation use7 daysmean duration per night auto-adaptative servo-ventilation was used during 7 days
SAS prevalence3 monthsassessed by respiratory polygraphy
SAS severity3 monthsassessed by apnea-hypopnea-index meseared by respiratory polygraphy, mild if AHI is 5-15/h, moderate if AHI is 15-30/h and severe if AHI is \> 30/h
Neurological outcome3 monthsmodified Rankin score (mRS), from 0 (no disability) to 6 (dead)
Obstructive apnea index3 monthsassessed by respiratory polygraphy
Quality of life on SF-12 questionnaire3 monthsSF-12 (Short Form Survey 12) questionnaire (not a scale, result is shown as 2 numbers (physical and mental component scores) : if superior to 50, the quality of life is better to the mean quality of life in general population, if less than 50, the quality of life is worse than in the general population)
Quality of sleep on Pittsburgh Sleep Quality Index3 monthsPittsburgh Sleep Quality Index, from 0 (good quality of sleep) to 21 (bas quality of sleep)
Daytime Sleepiness3 monthsEpworth Sleepiness Scale, from 0 (no sleepiness) to 24 (great sleepiness), sleepiness if \> 10
Central apnea index3 monthsassessed by respiratory polygraphy

Countries

France

Contacts

Primary ContactElena Meseguer, MD
elena.meseguer@aphp.fr01 40 25 74 86

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026